Shepherd JH, Ballman K, Polley MC, Campbell JD, et al. CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer. J Clin Oncol 2022 Jan 19:JCO2101506. doi: 10.1200/JCO.21.01506.
PMID: 35044810